Evidence map›Paper›PMID 37205422›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

Scott W Woods, Sophie Parker, Melissa J Kerr, Barbara C Walsh, S Andrea Wijtenburg, Nicholas Prunier, Angela R Nunez, Kate Buccilli, Catalina Mourgues-Codern, Kali Brummitt and 33 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors.

Scott W WoodsDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Sophie ParkerDivision of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
Melissa J KerrOrygen, Parkville, Victoria, Australia.
Barbara C WalshDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
S Andrea WijtenburgDivision of Translational Research, National Institute of Mental Health, Bethesda, MD, USA.
Nicholas PrunierDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Angela R NunezDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Kate BuccilliOrygen, Parkville, Victoria, Australia.
Catalina Mourgues-CodernDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Kali BrummittDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB Canada.
Kyle S KinneyDepartment of Psychology & Neuroscience, Temple University, Philadelphia, PA, USA.
Carli TranklerDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Julia SzaciloCAMEO, Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Beau-Luke ColtonDivision of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
Munaza AliDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Anastasia HaidarDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Tashrif BillahDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Kevin HuynhOrygen, Parkville, Victoria, Australia.
Uzair AhmedOrygen, Parkville, Victoria, Australia.
Laura L AderyDepartments of Psychiatry and Biobehavioral Sciences & Psychology, University of California, Los Angeles, CA, USA.
Cheryl M CorcoranDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Diana O PerkinsDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
Jason SchiffmanDepartment of Psychological Science, University of California, Irvine, CA, USA.
Jesus PerezCAMEO, Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Daniel MamahDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB Canada.
Lauren M EllmanDepartment of Psychology & Neuroscience, Temple University, Philadelphia, PA, USA.
Albert R PowersDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Michael J ColemanDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Alan AnticevicDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Paolo Fusar-PoliDepartment of Psychosis Studies, King's College London, UK.
John M KaneDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.
Rene S KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Patrick D McGorryOrygen, Parkville, Victoria, Australia.
Carrie E BeardenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Martha E ShentonDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Barnaby NelsonOrygen, Parkville, Victoria, Australia.
Monica E CalkinsDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.
Larry HendricksOrygen, Parkville, Victoria, Australia.
Sylvain BouixDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Jean AddingtonDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB Canada.
Thomas H McGlashanDepartment of Psychiatry, Yale University School of Medicine, New Haven CT, USA.
Alison R YungDivision of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
Accelerating Medicines Partnership Schizophrenia

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination CenterU24MH124629 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI Rene S. Kahn, Martha E. Shenton · 2020 to 2026
$32.6M
Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)U01MH124631 · NIMH · UNIVERSITY OF MELBOURNE · PI Christopher Barnaby Nelson · 2020 to 2026
$30.4M
Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark D Shen · 2020 to 2026
$9.7M
NICHD NIH HHS P50 HD103573NIMH NIH HHS U01 MH124631NIMH NIH HHS U01 MH124639NIMH NIH HHS U24 MH124629Wellcome Trust
6 · The paper itself

Abstract

Aim: To harmonize two ascertainment and severity rating instruments commonly used for the clinical high risk syndrome for psychosis (CHR-P): the Structured Interview for Psychosis-risk Syndromes (SIPS) and the Comprehensive Assessment of At-Risk Mental States (CAARMS). Methods: The initial workshop is described in the companion report from Addington et al. After the workshop, lead experts for each instrument continued harmonizing attenuated positive symptoms and criteria for psychosis and CHR-P through an intensive series of joint videoconferences. Results: Full harmonization was achieved for attenuated positive symptom ratings and psychosis criteria, and partial harmonization for CHR-P criteria. The semi-structured interview, named P ositive SY mptoms and Diagnostic Criteria for the C AARMS H armonized with the S IPS (PSYCHS), generates CHR-P criteria and severity scores for both CAARMS and SIPS. Conclusion: Using the PSYCHS for CHR-P ascertainment, conversion determination, and attenuated positive symptom severity rating will help in comparing findings across studies and in meta-analyses.

Identifiers

PMID37205422
PMCPMC10187348

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.